Anti-Insulin receptor (INSR) Monoclonal Antibody (Clone 18-44)
Anti-Insulin receptor (INSR) Monoclonal Antibody (Clone 18-44)
Product No.: 50104
- -
- -
Clone 18-44 Target Insulin receptor (α subunit) Formats AvailableView All Product Type Monoclonal Alternate Names IR, EC 2.7.10.1, CD antigen CD220 [Cleaved into: Insulin receptor subunitα; Insulin receptor subunit β] Isotype Mouse IgG2b Applications Act , IP , WB , Inhibitor , Stimulation |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Immunogen Human placental insulin receptor Product Concentration Lot Specific Formulation This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. State of Matter Liquid Product Preparation Purified by Protein G affinity chromatography Storage and Handling This monoclonal antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone 18-44 a monoclonal antibody is specific to human insulin receptor; low-level cross-reactivity with bovine and rabbit samples.
and rabbit insulin receptor. Background The insulin receptor (INSR) is a crucial receptor tyrosine kinase (RTK) that plays a central role in regulating glucose uptake in the body. When insulin binds to the extracellular domain of the INSR, it triggers a cascade of events leading to the absorption of glucose by cells. The INSR shares significant structural and functional similarities with the IGF-1 receptor (IGF-1R), highlighting their related roles in cellular signaling. One of the earliest cellular responses to insulin stimulation is the autophosphorylation of tyrosine residues within the INSR, a critical step in initiating the downstream signaling pathways. In humans, the gene encoding the INSR is located on chromosome 19. Dysfunctions or defects in the INSR can lead to a range of insulin resistance syndromes, impacting the body's ability to respond effectively to insulin. Similarly, defects in the IGF-1R can contribute to certain forms of growth retardation. Function Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically rUniProtKB:P15208, PubMed:12138094, PubMed:16314505, PubMed:16831875, PubMed:8257688, PubMed:8276809, PubMed:8452530, PubMed:9428692}. NCBI Gene Bank ID UniProt.org Research Area Growth Factors, Cytokines, Receptors References & CitationsSoos et al. (1986) Biochem J 235: 199. Brindle et al. (1990) Biochem J 268: 615. Prigent et al. (1990) J Biol Chem 265: 9970 Technical ProtocolsCertificate of Analysis |
Formats Available
